Zimmer Holdings

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Founded Warsaw, Indiana, U.S. (1927)
Founders Justin O. Zimmer
Headquarters Warsaw, Indiana, USA
Key people David C Dvorak (President/CEO)
Revenue US$ 4.62 billion (2013)[1]
Website www.zimmer.com

Zimmer Holdings Inc. (NYSEZMH) is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

In 2001 Zimmer was spun off from Bristol-Myers Squibb and begins trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the Company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the Company acquired Reno, Nevada-based Synvasive Technology, Inc.

The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.


Zimmer designs, develops, manufactures and markets orthopaedics products like knee, hip, shoulder, elbow, foot and ankle artificial joints and dental protesis. Zimmer has operations in more than 25 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Deutschland, India, Israel, Italy, Japan, Latin America, Nedherland, Brasil, Portugal, Russia, South Africa, Spain etc. and sells products in more than 100 countries.[2]

In British English, a "Zimmer frame" has become a genericized trademark term for a walking frame.

Corporate history[edit]

On 24 April, 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion. [3]

Company data[edit]

Zimmer's 2013 sales were approximately $4.62 billion. The company is supported by the efforts of approximately 9,000 employees worldwide.

Key executives[edit]

Zimmer leadership includes the following individuals:[4]

  • David C Dvorak, President/CEO
  • Joseph A Cucolo, Pres:Americas Sales
  • James T Crines, Exec VP:Finance/CFO
  • Chad F Phipps, Senior VP/Secretary/Gen Cnsl
  • Robert J Marshall Jr "Bob", VP:Investor Relations


External links[edit]